JP2022553839A5 - - Google Patents
Info
- Publication number
- JP2022553839A5 JP2022553839A5 JP2022525948A JP2022525948A JP2022553839A5 JP 2022553839 A5 JP2022553839 A5 JP 2022553839A5 JP 2022525948 A JP2022525948 A JP 2022525948A JP 2022525948 A JP2022525948 A JP 2022525948A JP 2022553839 A5 JP2022553839 A5 JP 2022553839A5
- Authority
- JP
- Japan
- Prior art keywords
- here
- antibody
- amino acid
- seq
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (27)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962929601P | 2019-11-01 | 2019-11-01 | |
| US201962929194P | 2019-11-01 | 2019-11-01 | |
| US201962929137P | 2019-11-01 | 2019-11-01 | |
| US201962929288P | 2019-11-01 | 2019-11-01 | |
| US201962929283P | 2019-11-01 | 2019-11-01 | |
| US201962929347P | 2019-11-01 | 2019-11-01 | |
| US201962929207P | 2019-11-01 | 2019-11-01 | |
| US62/929,207 | 2019-11-01 | ||
| US62/929,288 | 2019-11-01 | ||
| US62/929,601 | 2019-11-01 | ||
| US62/929,347 | 2019-11-01 | ||
| US62/929,194 | 2019-11-01 | ||
| US62/929,137 | 2019-11-01 | ||
| US62/929,283 | 2019-11-01 | ||
| US201962940742P | 2019-11-26 | 2019-11-26 | |
| US62/940,742 | 2019-11-26 | ||
| US202062978147P | 2020-02-18 | 2020-02-18 | |
| US62/978,147 | 2020-02-18 | ||
| US202063015348P | 2020-04-24 | 2020-04-24 | |
| US63/015,348 | 2020-04-24 | ||
| US202063046164P | 2020-06-30 | 2020-06-30 | |
| US202063046046P | 2020-06-30 | 2020-06-30 | |
| US63/046,164 | 2020-06-30 | ||
| US63/046,046 | 2020-06-30 | ||
| US202063084903P | 2020-09-29 | 2020-09-29 | |
| US63/084,903 | 2020-09-29 | ||
| PCT/US2020/058373 WO2021087368A2 (en) | 2019-11-01 | 2020-10-30 | Anti-cd45 antibodies and conjugates thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553839A JP2022553839A (ja) | 2022-12-26 |
| JP2022553839A5 true JP2022553839A5 (https=) | 2023-11-14 |
| JP7716399B2 JP7716399B2 (ja) | 2025-07-31 |
Family
ID=75715351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525948A Active JP7716399B2 (ja) | 2019-11-01 | 2020-10-30 | 抗－ｃｄ４５抗体及びそのコンジュゲート |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12570756B2 (https=) |
| EP (1) | EP4051711A4 (https=) |
| JP (1) | JP7716399B2 (https=) |
| KR (1) | KR20220091567A (https=) |
| CN (2) | CN121574249A (https=) |
| AU (1) | AU2020376934A1 (https=) |
| BR (1) | BR112022008371A2 (https=) |
| CA (1) | CA3156740A1 (https=) |
| IL (1) | IL292628A (https=) |
| MX (1) | MX2022005249A (https=) |
| TW (1) | TWI904109B (https=) |
| WO (1) | WO2021087368A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3877416A4 (en) | 2018-10-30 | 2022-07-27 | Magenta Therapeutics, Inc. | ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF |
| WO2020092655A1 (en) * | 2018-10-30 | 2020-05-07 | Magenta Therapeutics, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
| IL292628A (en) | 2019-11-01 | 2022-07-01 | Magenta Therapeutics Inc | Anti-cd45 antibody and conjugates accordingly |
| US20250326856A1 (en) * | 2022-05-31 | 2025-10-23 | Fred Hutchison Cancer Center | Humanized anti-cd45 antibodies and uses thereof |
| WO2024064771A1 (en) * | 2022-09-20 | 2024-03-28 | Vor Biopharma Inc. | Anti-cd45-ign antibody drug conjugates and uses thereof |
| IL321599A (en) * | 2022-12-23 | 2025-08-01 | Cimeio Therapeutics Ag | Antibodies targeting cd45 |
| WO2025064944A1 (en) * | 2023-09-20 | 2025-03-27 | Vor Biopharma Inc. | Anti-cd45 antibody-drug conjugate pharmaceutical compositions |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
| CN120554516B (zh) * | 2025-07-30 | 2025-10-24 | 杭州华大生命科学研究院 | 抗cd45抗体及其应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7112661B1 (en) * | 1998-10-30 | 2006-09-26 | The Research Foundation Of State University Of New York | Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein Ib alpha |
| CN101356189A (zh) * | 2005-11-10 | 2009-01-28 | 受体生物公司 | 肝细胞生长因子内含子融合蛋白 |
| AR056857A1 (es) * | 2005-12-30 | 2007-10-24 | U3 Pharma Ag | Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos |
| AU2007284651B2 (en) | 2006-08-09 | 2014-03-20 | Institute For Systems Biology | Organ-specific proteins and methods of their use |
| WO2008085878A2 (en) * | 2007-01-03 | 2008-07-17 | Morphotek, Inc. | High affinity antibodies that neutralize staphylcoccus enterotoxin b |
| JP2010532158A (ja) * | 2007-04-02 | 2010-10-07 | アムジェン フレモント インク． | 抗ＩｇＥ抗体 |
| US9243057B2 (en) * | 2010-08-31 | 2016-01-26 | The Regents Of The University Of California | Antibodies for botulinum neurotoxins |
| KR102276528B1 (ko) * | 2011-09-30 | 2021-07-12 | 추가이 세이야쿠 가부시키가이샤 | 이온 농도 의존성 결합 분자 라이브러리 |
| CN104178454B (zh) * | 2013-05-24 | 2019-03-08 | 益善生物技术股份有限公司 | 一种循环肿瘤细胞的富集、分析方法 |
| ES3007999T3 (en) * | 2015-04-21 | 2025-03-21 | Genentech Inc | Compositions and methods for prostate cancer analysis |
| GB201601073D0 (en) * | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibodies |
| US20170189548A1 (en) | 2015-11-25 | 2017-07-06 | Immunogen, Inc. | Pharmaceutical formulations and methods of use thereof |
| WO2017155937A1 (en) * | 2016-03-07 | 2017-09-14 | Actinium Pharmaceuticals, Inc. | Stabilized radiolabeled anti-cd45 immunoglobulin compositions |
| CN109641051A (zh) * | 2016-06-17 | 2019-04-16 | 美真达治疗公司 | 用于耗尽细胞的组合物和方法 |
| JP2020530280A (ja) * | 2017-07-03 | 2020-10-22 | トルク セラピューティクス， インコーポレイテッド | 免疫刺激性融合分子およびその使用 |
| CN109991410B (zh) * | 2017-12-29 | 2022-07-05 | 上海白泽医学检验所有限公司 | 一种含抗cd45单抗的组合物及其使用方法 |
| AU2019366960A1 (en) | 2018-10-23 | 2021-05-27 | Regeneron Pharmaceuticals, Inc. | Fc silenced antibody drug conjugates (ADCs) and uses thereof |
| US20200376135A1 (en) | 2018-10-23 | 2020-12-03 | Magenta Therapeutics, Inc. | Fc silenced antibody drug conjugates (adcs) and uses thereof |
| EP3877416A4 (en) * | 2018-10-30 | 2022-07-27 | Magenta Therapeutics, Inc. | ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF |
| IL292628A (en) | 2019-11-01 | 2022-07-01 | Magenta Therapeutics Inc | Anti-cd45 antibody and conjugates accordingly |
| WO2021168128A1 (en) * | 2020-02-18 | 2021-08-26 | Magenta Therapeutics, Inc. | Compositions and methods for allogeneic transplantation |
-
2020
- 2020-10-30 IL IL292628A patent/IL292628A/en unknown
- 2020-10-30 CN CN202511554650.5A patent/CN121574249A/zh active Pending
- 2020-10-30 WO PCT/US2020/058373 patent/WO2021087368A2/en not_active Ceased
- 2020-10-30 TW TW109137991A patent/TWI904109B/zh active
- 2020-10-30 BR BR112022008371A patent/BR112022008371A2/pt unknown
- 2020-10-30 CA CA3156740A patent/CA3156740A1/en active Pending
- 2020-10-30 AU AU2020376934A patent/AU2020376934A1/en active Pending
- 2020-10-30 MX MX2022005249A patent/MX2022005249A/es unknown
- 2020-10-30 EP EP20880619.0A patent/EP4051711A4/en active Pending
- 2020-10-30 JP JP2022525948A patent/JP7716399B2/ja active Active
- 2020-10-30 CN CN202080086243.5A patent/CN114846028B/zh active Active
- 2020-10-30 KR KR1020227018323A patent/KR20220091567A/ko active Pending
-
2021
- 2021-10-22 US US17/452,028 patent/US12570756B2/en active Active
-
2024
- 2024-03-07 US US18/598,342 patent/US12209135B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022553839A5 (https=) | ||
| JP2025160215A5 (https=) | ||
| JP2022512629A5 (https=) | ||
| JP7650819B2 (ja) | 抗－ｃｄ４５抗体薬物コンジュゲート及びその使用 | |
| JP7791923B2 (ja) | Ｃｄ５＋細胞の枯渇のための組成物および方法 | |
| JP2022530089A5 (https=) | ||
| CN106414465B (zh) | 带电荷链接体及其在共轭反应上的应用 | |
| AU2021225125B9 (en) | Antibody drug conjugate loaded with binary toxins and its application | |
| CN105849086B (zh) | 亲水性链接体及其在药物分子和细胞结合分子共轭反应上的应用 | |
| JP2020504112A5 (https=) | ||
| JP2022163075A (ja) | 細胞の枯渇のための組成物および方法 | |
| US10576161B2 (en) | Compositions and methods for the depletion of CD137+ cells | |
| JP5314590B2 (ja) | カンプトテシン結合部分 | |
| JP2019522050A5 (https=) | ||
| RU2014116878A (ru) | Цитотоксические пептиды и их конъюгаты антитело-лекарственное средство | |
| JP2016505019A5 (https=) | ||
| JP2015534579A5 (https=) | ||
| CN107683146A (zh) | 位点特异性抗体‑药物缀合物 | |
| JP2025183307A5 (https=) | ||
| US20220175944A1 (en) | Anti-cd117 antibody-drug conjugates and uses thereof | |
| CN108601952B (zh) | 雷公藤内酯的葡萄糖缀合物、类似物及其用途 | |
| JP2022530438A5 (https=) | ||
| US20220177577A1 (en) | Anti-cd117 antibody drug conjugates and uses thereof | |
| WO2019108860A4 (en) | Compositions and methods for the depletion of cd2+ cells | |
| JP2022531141A5 (https=) |